Single-day HER2neu amplification assessment using chip-based digital PCR in formalin-fixed paraffn-embedded breast carcinoma tissue
Introduction: Human epidermal growth factor receptor 2 (HER2) amplification is present in almost 15%-20% of breast cancer tumors, making it an important parameter for testing. The present study was designed to evaluate a chip-based digital PCR (dPCR) system for assessing HER2 amplification from form...
Saved in:
Published in | Breast cancer targets and therapy Vol. 10; p. 121 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Dove Medical Press Limited
01.01.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Introduction: Human epidermal growth factor receptor 2 (HER2) amplification is present in almost 15%-20% of breast cancer tumors, making it an important parameter for testing. The present study was designed to evaluate a chip-based digital PCR (dPCR) system for assessing HER2 amplification from formalin-fixed paraffin-embedded breast carcinoma tissue and to compare this system with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH).Materials and methods: A total of 84 breast carcinoma tissue samples were analyzed by IHC, FISH, and chip-based dPCR in a blinded manner.Results: All nine IHC-positive and 35 IHC-negative samples had equivalent results with dPCR, taking an amplification ratio threshold of 1.8 as a positive result. Of the 40 IHC equivocal samples, 10 were assessed as positive, 27 as negative, and three as equivocal by dPCR.Conclusion: These results demonstrate that chip-based dPCR is suitable for HER2 amplification detection in formalin-fixed paraffin-embedded samples in a clinical setting, providing the advantages of superior turnaround time, cost-effectiveness, and increased precision with absolute quantification compared with conventional tests such as FISH and IHC. This methodology was especially beneficial in tissue samples with low DNA concentration.Keywords: HER2, digital PCR, IHC, FISH, breast cancer |
---|---|
ISSN: | 1179-1314 1179-1314 |
DOI: | 10.2147/BCTT.S161264 |